Furthermore, receiver-operating characteristic (ROC) curve analysis was used to assess the LYZ gene’s diagnostic effectiveness in glioblastoma patients, suggesting that it may be used as a diagnostic biomarker (Figure 2D). Here, LYZ is linked to glioblastoma.